Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Immix Biopharma Stock Price, Quotes and Forecasts | NASDAQ:IMMX | Benzinga

Q: What sector and industry does Immix Biopharma (IMMX) operate in?

Immix Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Immix Biopharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IMMX.

Open	$1.46
Close	$1.57
Volume / Avg.	49.14K / 65.84K
Day Range	$1.36 - $1.64
52 Wk Range	1.26 - 2.93
Market Cap	$41.03M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	3.92%
Days to Cover	6.71

Recent News

Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance.

Avi Kapoor

What's Going On With Cancer-Focused Immix Biopharma Stock Today?

Immix Biopharma Inc (NASDAQ: IMMX) announced the presentation of updated data from the ongoing Phase 1b/2 NEXICART-1 study of its NXC-201, an autologous, BCMA-targeted chimeric antigen receptor T

Vandana Singh

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.46
Close	$1.57
Volume / Avg.	49.14K / 65.84K
Day Range	$1.36 - $1.64
52 Wk Range	1.26 - 2.93
Market Cap	$41.03M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	3.92%
Days to Cover	6.71

About Immix Biopharma Inc

Sector

Health Care

Industry

Biotechnology

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematolo...

Got Questions? Ask

Analyze IMMX's market performance

Show IMMX's technical analysis

What are analysts' targets for IMMX?

What is IMMX's current price trend?

What is IMMX's dividend yield?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Immix Biopharma (IMMX) stock?

You can purchase shares of Immix Biopharma (NASDAQ:IMMX) through any online brokerage.

View our list of the best stock brokerages

Who are Immix Biopharma (IMMX) competitors?

Other companies in Immix Biopharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Skye Bioscience (NASDAQ:SKYE), Fortress Biotech (NASDAQ:FBIO), CytomX Therapeutics (NASDAQ:CTMX) and Gain Therapeutics (NASDAQ:GANX).

What is the forecast, or price target, for Immix Biopharma (IMMX) stock?

Immix Biopharma has a consensus price target of $10.50.

What is the current price for Immix Biopharma (IMMX)?

The stock price for Immix Biopharma (NASDAQ: IMMX) is $1.48 last updated April 11, 2025 at 7:26 PM EDT.

Does Immix Biopharma (IMMX) pay a dividend?

There are no upcoming dividends for Immix Biopharma.

When is Immix Biopharma (NASDAQ:IMMX) reporting earnings?

Immix Biopharma’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Immix Biopharma (IMMX) going to split?

There is no upcoming split for Immix Biopharma.

What sector and industry does Immix Biopharma (IMMX) operate in?

Immix Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Immix Biopharma Stock Price, Quotes and Forecasts

Immix Biopharma (IMMX) Forecast